KFA Private Wealth Group’s West Pharmaceutical WST Stock Holding History

KFA Private Wealth Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Hold	1,500	–	–	0.13%	75
2026 Q1	$376K	Hold	1,500	–	–	0.09%	108
2025 Q4	$413K	Hold	1,500	–	–	0.1%	93
2025 Q3	$393K	Hold	1,500	–	–	0.11%	85
2025 Q2	$328K	Hold	1,500	–	–	0.1%	97
2025 Q1	$336K	Hold	1,500	–	–	0.12%	78
2024 Q4	$491K	Hold	1,500	–	–	0.21%	48
2024 Q3	$450K	Hold	1,500	–	–	0.21%	44
2024 Q2	$494K	Hold	1,500	–	–	0.26%	44
2024 Q1	$594K	Hold	1,500	–	–	0.18%	51
2023 Q4	$528K	Hold	1,500	–	–	0.19%	45
2023 Q3	$563K	Hold	1,500	–	–	0.23%	39
2023 Q2	$574K	Hold	1,500	–	–	0.24%	39
2023 Q1	$520K	Buy	+1,500	New	+$438K	0.24%	39

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

KFA Private Wealth Group's WST Position: Q2 2026 in Review

KFA Private Wealth Group held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,500 shares worth $539K. The position accounts for 0.13% of the portfolio, ranked #75.

KFA Private Wealth Group first reported a position in WST in Q1 2023 and has held it in 14 quarters since. The position peaked at $594K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

KFA Private Wealth Group held 1,500 shares of West Pharmaceutical worth $539K as of Q2 2026.
KFA Private Wealth Group left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.13% of KFA Private Wealth Group's portfolio in Q2 2026, its #75 holding.
KFA Private Wealth Group first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
KFA Private Wealth Group's West Pharmaceutical position peaked at $594K in Q1 2024.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on KFA Private Wealth Group's 13F filing for Q2 2026, filed 28 Jul 2026.